Aragen Life Sciences

Aragen Life Sciences is a prominent discovery research and development organization in Asia, providing a comprehensive range of services across the R&D and manufacturing value chain. The company specializes in drug discovery, clinical development, contract manufacturing, formulation, and informatics, catering to the needs of healthcare institutions and other sectors. With over a decade of experience in delivering innovative drug discovery and development services, Aragen is equipped with a team of skilled scientists and advanced technologies that enable them to achieve exceptional results for their clients. The organization employs approximately 2,400 professionals and serves a diverse global customer base, including prominent players in pharmaceuticals, agrochemicals, electronics, biotechnology, and academia. Aragen Life Sciences is recognized for its commitment to quality, speed, and affordability, consistently meeting and exceeding customer expectations in their research endeavors.

Sudhir Kumar Singh

COO

3 past transactions

Intox

Acquisition in 2021
INTOX offers a wide range of non-clinical in-vivo and in-vitro research services to cater to the product development and registration needs of diverse industries and research communities.

Vanta Bioscience

Acquisition in 2014
Vanta Bioscience Limited operates as a preclinical contract research organization based in Secunderabad, India, with additional research laboratories in Chennai and offices in Brussels and West Des Moines. The company provides a wide range of preclinical safety assessment services to clients across various industries, including pharmaceuticals, medical devices, biotechnology, cosmetics, agrochemicals, and nutraceuticals. Its offerings encompass toxicology testing, biocompatibility studies, chemical safety assessments, and risk evaluations for active pharmaceutical ingredients and other materials. Vanta Bioscience also engages in research and development activities, focusing on drug discovery, biological products, vaccines, gene-based therapies, diagnostics, and cosmetic research. Established in 2016, the organization is dedicated to delivering comprehensive non-clinical safety assessment services on a global scale.

Aragen Bioscience

Acquisition in 2014
Aragen Bioscience, Inc. provides preclinical contract research and development services. The company specializes in recombinant cell line and hybridoma development, cell culture and protein purification process development and production, primary and immortalized cell-based assays, in vivo models of human disease and custom immunological services for the pharmaceutical and biotech industries.Aragen Bioscience, Inc. was founded in 2006 and is based in Morgan Hill, California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.